BioSpace News Archive

ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, today announced that two abstracts containing new data on ASLAN003 have been accepted for poster presentation at the upcoming 60th American Society of Hematology (ASH) Annual Meeting in San Diego, US on 1 – 4 December 2018.

Emmaus Life Sciences, Inc. announced today that its abstract has been accepted for poster presentation at the American Society of Hematology (ASH) 2018 Annual Meeting taking place in San Diego, California from December 1 - 4.

Doug and Leah Mickschl are using the power of creativity and love to find a cure for type 1 diabetes.

Novartis will present new research that may transform the way serious blood diseases and a certain type of breast cancer are treated at the upcoming 60th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego, December 1-4 and the 41st Annual San Antonio Breast Cancer Symposium (SABCS), December 4-8